Citi Reiterates Sell Rating on Hims and Hers (HIMS), Comments on Novo's Wegovy Price Promo: 'We see this as another potential headwind for HIMS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 rises; Apple and Palantir set to report results
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| (NYSE: HIMS) | Delayed: 26.48 -1.2 (4.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.68 | 52 Week High | $ | |||
| Open | $27.97 | 52 Week Low | $ | |||
| Day High | $28.49 | P/E | N/A | |||
| Day Low | $26.42 | EPS | $ | |||
| Volume | 6,242,861 | |||||
| NOVARTIS AG (NYSE: NVS) | Delayed: 161.41 +0.62 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $160.79 | 52 Week High | $89.15 | |||
| Open | $160.54 | 52 Week Low | $69.84 | |||
| Day High | $161.51 | P/E | N/A | |||
| Day Low | $160.11 | EPS | $0.00 | |||
| Volume | 1,110,220 | |||||
